Current European Society of Cardiology Guidelines recommend concomitant atrial fibrillation (AF) ablation for all symptomatic patients undergoing other cardiac surgeries, but the safety and potential benefits of concomitant atrial fibrillation (AF) ablation at the time of double valve replacement remains unexamined. A retrospective review of patients with AF who underwent double valve replacement with or without concomitant surgical ablation in our institute starting from April 2006.
Persistent AF was defined as AF lasting more than 7 days and long-standing persistent AF as continuous AF for more than 12 months. Concomitant surgical AF ablation was offered to suitable patients as determined by the surgeon, and patients then decided whether to undergo the additional procedure. The operations were performed through median sternotomy and under cardiopulmonary bypass. The bipolar ablation clamp was positioned precisely around the pulmonary veins (PV) for bilateral circular ablation. After Marsh ligament cutting and cross-clamping the ascending aorta, the left atrial appendage was resected and left atrial cavity exposed through an incision behind the interatrial groove. Then, linear ablations were performed between the left and right inferior PVs, between the left and right superior PVs, between the left superior PV and the opening of the left atrial appendage, and between the line connecting bilateral inferior PVs and the mitral valve isthmus. Ablation at the right atrium was then performed. Briefly, the bipolar ablation clamp was positioned around the inferior vena cava (IVC) and right atrial appendage for circular ablation. An L-shaped incision was then made on the anterior wall of the right atrium and linear ablations were performed vertically from the incision to the interatrial groove and tricuspid annulus, to the ablation ring around the right atrial appendage, and from the superior vena cava to the ablation ring around the inferior vena cava. The left atrial appendage was always excluded by resection and the incision was closed with continuous running stitches. Temporary pacemakers were placed in all patients and activated when heart rate was less than 70 beats per minute.
Study Type
OBSERVATIONAL
Enrollment
500
After median sternotomy, cardiopulmonary bypass was established via bicaval and aortic cannulation. After cross-clamping of the aorta and cardioplegia, mitral and aortic replacement were performed. Supplementary procedures such tricuspid annuloplasty, ascending aorta replacement and coronary artery bypass grafting were performed as required. The left atrial appendage was excised to avoid thrombus formation.
Both left and right atrial ablation were performed using a bi-polar radiofrequency ablation clamp.
Guangzhou General Hospital of Guangzhou Military Command
Guangzhou, Guangdong, China
RECRUITINGmortality
mortality from any cause
Time frame: from the date of the surgery until the date of death, assess up to 120 months
sinus rhythm rate
sinus rhythm rate examined by 24h holter monitoring
Time frame: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
stroke
perioperative stroke
Time frame: from the date of surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
third degree heart block requiring permanent pacemaker implantation
third degree heart block diagnosed via ECG
Time frame: from the date of surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
perioperative morbidities
Redo for bleeding; Low cardiac output syndrome; Renal failure requiring dialysis; Pneumonia;
Time frame: from the date of surgery until the date of first documented progression or date of death from any cause, assess up to 30 days
Warfarin-related bleeding
bleeding events occurred during the period when warfarin was used
Time frame: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
Thromboembolic events
thromboembolic events
Time frame: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
New York Heart Function classification
New York Heart Function classification
Time frame: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
warfarin requirement
oral warfarin requirement over 6 moths after the surgery
Time frame: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
left ventricular ejection fraction
left ventricular ejection fraction measured by transthoracic echocardiography
Time frame: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
left atrium diameter
left atrium diameter measured by transthoracic echocardiography
Time frame: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months